Generation of dendritic cells from patients with chronic myelogenous leukemia

Annals of Hematology

Volumn 78, Issue 4, 1999, Pages 181-186

  Heinzinger, M ^a,b   Waller, C F ^a   Von Den Berg, A ^a   Rosenstiel, A ^a   Lange, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CML; Dendritic cell; FICTION; FISH

Indexed keywords

B7 ANTIGEN; BCR ABL PROTEIN; CD1 ANTIGEN; CD23 ANTIGEN; CD34 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HLA DR ANTIGEN; T6 ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL FRACTIONATION; CELL STRUCTURE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DENDRITIC CELL; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MONOCYTE; PERIPHERAL CIRCULATION; PHILADELPHIA 1 CHROMOSOME; PINOCYTOSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; CELL COUNT; CELL DIVISION; DENDRITIC CELLS; DEXTRANS; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HLA-DR ANTIGENS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PHENOTYPE;

EID: 0032938515     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050497     Document Type: Article

References (24)

1. Fialkow PJ, Jacobson RJ, Papayannopoulou TH (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125-130
2. Bakhshi A, Minowada J, Arnold A, Cossman J, Jensen JP, Whang-Peng J, Waldmann TA, Korsmeyer SJ (1983) Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med 309:826-831
3. Rowley J (1990) The Philadelpia chromosome translocation: a paradigm for understanding leukemia. Cancer 65:2178-2184
4. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M (1983) Translocation of the c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306:277-280
5. Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550-556
6. Saglio G, Pane F, Gottardi E, Frigeri F, Buonaiuto MR, Guerrasio A, De Micheli D, Parziale, A, Fornaci MN, Martinelli G, Salvatore F (1996) Consistent amounts of acute leukemia associated p190 BCR/ ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87:1075-1081
7. Daley GQ, van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science: 247:824-830
8. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N (1995) BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood 86:4603-4611
9. Ten Bosch GJA, Joosten AM, Kessler JH, Melief CJM, Leeksma OC (1996) Recognition of bcr/abl positive leukemic blasts by human CD4+ T-cells elicited by primary in vitro immunization with bcr/abl breakpoint peptide. Blood 88:522-3527
10. Boccia M, Korontsvit T, Mackinnon Xu Q, Young Yang S, Sette A, Scheinberg DA (1996) Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87:3587-3592
11. Eibl B, Ebner S, Duba C, Bock G, Romani N, Erdel M, Gachter A, Niederwieser D, Schuler G (1997) Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Gene Chromosome Cane 20:215-223
12. Weber-Matthiesen K, Winkelmann M, Müller-Hermelink A, Schlegelberger B, Grote W (1992) Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40:171-175
13. Mackensen A, Carcelain G, Viel S, Raynal M.C, Michalaki H, Triebel F, Bosq J, Hercend T (1994) Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 93:1397-1402
14. Sallusto F, Lanzavecchia A (1995) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor . J Exp Med 179:1109-1118
15. Sallusto F, Cella M, Danieli C, Lanzavecchia A(1995) Dendritic cells used macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class 11 compartment: downregulation by cytokines and bacterial products. J Exp Med: 182:389-400
16. Boccia M, Wentworth PA, Southwood S, Sidny J, McGrawK, Scheinberg DA, Sette A (1995) Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 85:2680-2684
17. bcr-abl protein. Proc Natl Acad Sci U S A 89:1468-1472
18. Herbst B, Köhler G, Mackensen A, Veelken H, Kulmburg P, Rosenthal FM, Schaefer HE, Mertelsmann R, Fisch P, Lindemann A (1996) In vitro differentation of CD 34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the Birbeck Granula and MIIC-positive Langerhans cell and the interdigitating dendritic cell type. Blood: 88:2541-2548
19. Rapso G, Nijman HW, Stoorvogel W, Leijndekker, Harding CV, Melief CJM, Geuze HJ (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161-1169
20. Nijman HW, Kleijmeer MJ, Ossevoort MA, Oorschot VMJ, Vierboom MPM, van de Keur M, Kenemans P, Kast WM, Geuze HJ, Melief CJM (1995) Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med 182:163-171
21. Rock KL, Rothstein L, Gamble S, Fleischacker C (1993) Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150:438-446
22. Lanzavecchia A (1996) Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8:348-354
23. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreeff M and Champlin RE (1997) Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome positive chronic myelogenous leukemia. Blood 89:1133-1142
24. + peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis. Br J Haematol 99:490-499